Counterpoint Mutual Funds LLC Makes New Investment in Reinsurance Group of America, Incorporated $RGA

Counterpoint Mutual Funds LLC bought a new position in Reinsurance Group of America, Incorporated (NYSE:RGA) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 2,799 shares of the insurance provider’s stock, valued at approximately $571,000.

Other large investors have also recently modified their holdings of the company. Goldman Sachs Group Inc. boosted its position in Reinsurance Group of America by 44.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 221,198 shares of the insurance provider’s stock valued at $43,554,000 after acquiring an additional 67,880 shares in the last quarter. Focus Partners Wealth grew its holdings in shares of Reinsurance Group of America by 121.2% during the 1st quarter. Focus Partners Wealth now owns 2,676 shares of the insurance provider’s stock worth $527,000 after acquiring an additional 1,466 shares during the period. Geneos Wealth Management Inc. raised its position in shares of Reinsurance Group of America by 17.6% in the 1st quarter. Geneos Wealth Management Inc. now owns 388 shares of the insurance provider’s stock worth $76,000 after acquiring an additional 58 shares in the last quarter. Gabelli Funds LLC bought a new position in shares of Reinsurance Group of America in the 2nd quarter worth approximately $1,006,000. Finally, Cerity Partners LLC lifted its stake in shares of Reinsurance Group of America by 15.5% in the 2nd quarter. Cerity Partners LLC now owns 33,716 shares of the insurance provider’s stock valued at $6,688,000 after purchasing an additional 4,527 shares during the period. Institutional investors own 95.11% of the company’s stock.

Insider Buying and Selling at Reinsurance Group of America

In related news, EVP Ronald Herrmann sold 7,000 shares of Reinsurance Group of America stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $210.58, for a total value of $1,474,060.00. Following the completion of the sale, the executive vice president owned 3,938 shares of the company’s stock, valued at $829,264.04. The trade was a 64.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP John W. Hayden sold 414 shares of the company’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $214.95, for a total transaction of $88,989.30. Following the sale, the executive vice president directly owned 20,949 shares of the company’s stock, valued at $4,502,987.55. The trade was a 1.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on RGA. UBS Group lifted their price target on Reinsurance Group of America from $216.00 to $220.00 and gave the company a “neutral” rating in a research report on Thursday, April 9th. Evercore reiterated an “outperform” rating and issued a $267.00 price objective on shares of Reinsurance Group of America in a report on Monday, May 18th. Barclays raised their price objective on Reinsurance Group of America from $256.00 to $268.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Wall Street Zen raised shares of Reinsurance Group of America from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, JPMorgan Chase & Co. increased their price target on shares of Reinsurance Group of America from $264.00 to $270.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $251.25.

Reinsurance Group of America Stock Down 0.1%

Shares of NYSE:RGA opened at $220.69 on Friday. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.46. The stock has a fifty day simple moving average of $209.54 and a two-hundred day simple moving average of $207.68. Reinsurance Group of America, Incorporated has a 12-month low of $165.52 and a 12-month high of $229.21. The stock has a market capitalization of $14.46 billion, a price-to-earnings ratio of 11.96 and a beta of 0.47.

Reinsurance Group of America (NYSE:RGA) last posted its quarterly earnings results on Thursday, May 7th. The insurance provider reported $6.97 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.94. Reinsurance Group of America had a net margin of 4.92% and a return on equity of 13.16%. The firm had revenue of $6.49 billion for the quarter, compared to analysts’ expectations of $6.47 billion. During the same quarter in the prior year, the company posted $5.66 earnings per share. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. On average, research analysts anticipate that Reinsurance Group of America, Incorporated will post 26.88 earnings per share for the current fiscal year.

Reinsurance Group of America Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 2nd. Shareholders of record on Tuesday, May 19th were paid a dividend of $0.93 per share. The ex-dividend date was Tuesday, May 19th. This represents a $3.72 dividend on an annualized basis and a yield of 1.7%. Reinsurance Group of America’s payout ratio is currently 20.15%.

Reinsurance Group of America Profile

Reinsurance Group of America, Incorporated (NYSE: RGA) is a leading global provider of life and health reinsurance solutions. Headquartered in St. Louis, Missouri, RGA partners with primary insurance companies to help them manage risk, improve capital efficiency and develop innovative products. The company’s offerings span traditional risk transfer, financial solutions and facultative underwriting services, enabling clients to address a wide range of mortality, longevity, morbidity and critical-illness exposures.

RGA’s product suite includes life reinsurance, living benefits reinsurance, structured reinsurance and financial solutions that support product innovation and capital management.